Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
10:00am, Wednesday, 11'th Nov 2020
This biotech titan should be a top player on the merger and acquisition scene next year.
Aurinia Pharmaceuticals: Q3 Earnings Insights
04:30pm, Tuesday, 10'th Nov 2020
Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) fell 0.15% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 33.33% year over year to ($0.28
Aurinia Pharma's Dry Eye Study Blanks on Late-Stage Results
11:29am, Tuesday, 03'rd Nov 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares slid on Tuesday after the company reported results from its midstage study for the treatment of dry eye syndrome (DES).
Voclosporin has proven to be a safer and much more effective derivative of cyclosporin, whose emulsion eye drop formulation was approved by FDA in 2003 to treat DES.
Recap: Aurinia Pharmaceuticals Q2 Earnings
09:29pm, Tuesday, 11'th Aug 2020
Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) were unchanged after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 52.94% year over year to ($0.26
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Lags Revenue Estimates
09:15pm, Tuesday, 11'th Aug 2020
Aurinia (AUPH) delivered earnings and revenue surprises of -13.04% and -53.23%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
08:02pm, Tuesday, 11'th Aug 2020
AURINIA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS
Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for
04:30pm, Tuesday, 04'th Aug 2020
Aurinia (AUPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
10:05am, Tuesday, 04'th Aug 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at th
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020
10:05am, Thursday, 30'th Jul 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its second quarter 2020 financial results on Tuesday, August 11, 2020, after the markets clo
Aurinia Closes US$200 Million Public Offering of Common Shares
02:15pm, Monday, 27'th Jul 2020
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today annou
Why Aurinia Pharmaceuticals Dived by 16% on Thursday
10:59pm, Thursday, 23'rd Jul 2020
One day after moving higher in the market, Aurinia Pharmaceuticals (NASDAQ: AUPH) stock was deep in the loss column on Thursday. Optimism flowing from good news the previous day was erased by the Can
Aurinia Prices US$200 Million Public Offering of Common Shares
03:05am, Thursday, 23'rd Jul 2020
Aurinia Prices US$200 Million Public Offering of Common Shares
Aurinia Announces Public Offering of Common Shares
08:08pm, Wednesday, 22'nd Jul 2020
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today annou
Why Aurinia Pharmaceuticals Is Up Today
03:31pm, Wednesday, 22'nd Jul 2020
What happened? Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by 10.4% as of 11:15 a.m. EDT on Wednesday, after the company announced that the U.S. Food and Drug Administration (FDA) accepted
